(VIANEWS) - Falcon Minerals Corporation (FLMN), BayCom Corp (BCML), Edwards Lifesciences (EW) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Falcon Minerals Corporation (FLMN)
47.2% sales growth and 7.64% return on equity
Falcon Minerals Corporation acquires and owns mineral, royalty, and over-riding royalty interests in oil and natural gas properties in North America.
Falcon Minerals Corporation's sales growth this year is anticipated to be 68.9% and 186.8% for next year.
Year-on-year quarterly revenue growth grew by 103.6%, now sitting on 63.62M for the twelve trailing months.
Volume
Today's last reported volume for Falcon Minerals Corporation is 439466 which is 44.39% below its average volume of 790293.
Falcon Minerals Corporation's sales growth for the next quarter is 47.2%. The company's growth estimates for the present quarter and the next is 600% and 433.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.64%.
Falcon Minerals Corporation's Stock Yearly Top and Bottom Value
Falcon Minerals Corporation's stock is valued at $5.90 at 10:22 EST, way under its 52-week high of $6.58 and way higher than its 52-week low of $4.24.
Falcon Minerals Corporation's Moving Average
Falcon Minerals Corporation's value is way above its 50-day moving average of $5.22 and way above its 200-day moving average of $5.06.2. BayCom Corp (BCML)
35% sales growth and 8.03% return on equity
BayCom Corp operates as the bank holding company for United Business Bank that provides various financial services to businesses, business owners, and individuals.
BayCom Corp's sales growth this year is anticipated to be 32.4% and 7.4% for next year.
Year-on-year quarterly revenue growth grew by 9.4%, now sitting on 83.61M for the twelve trailing months.
Volume
Today's last reported volume for BayCom Corp is 49024 which is 18.25% above its average volume of 41455.
BayCom Corp's sales growth for the next quarter is 35%. The company's growth estimates for the current quarter and the next is 12.5% and negative -6.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.03%.
Volatility
BayCom Corp's last day, last week, and last month's current intraday variation average was 0.27%, 0.59%, and 0.73%, respectively.
BayCom Corp's highest amplitude of average volatility was 1.44% (day), 1.62% (last week), and 2.21% (last month), respectively.
BayCom Corp's Stock Yearly Top and Bottom Value
BayCom Corp's stock is valued at $22.45 at 10:22 EST, below its 52-week high of $22.73 and way higher than its 52-week low of $16.47.
BayCom Corp's Moving Average
BayCom Corp's worth is higher than its 50-day moving average of $20.67 and way above its 200-day moving average of $18.89.3. Edwards Lifesciences (EW)
18.2% sales growth and 32.6% return on equity
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally.
Edwards Lifesciences's sales growth this year is expected to be 21.4% and 11.1% for next year.
Year-on-year quarterly revenue growth grew by 48.8%, now sitting on 4.93B for the twelve trailing months.
Volume
Today's last reported volume for Edwards Lifesciences is 2013730 which is 22.99% below its average volume of 2614960.
Edwards Lifesciences's sales growth for the next quarter is 18.2%. The company's growth estimates for the ongoing quarter and the next is 5.9% and 12%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.6%.
Volatility
Edwards Lifesciences's last day, last week, and last month's current intraday variation average was 2.17%, 2.91%, and 1.82%, respectively.
Edwards Lifesciences's highest amplitude of average volatility was 3.45% (day), 3.46% (last week), and 2.98% (last month), respectively.
Edwards Lifesciences's Stock Yearly Top and Bottom Value
Edwards Lifesciences's stock is valued at $103.45 at 10:22 EST, way below its 52-week high of $123.27 and way above its 52-week low of $78.34.
Edwards Lifesciences's Moving Average
Edwards Lifesciences's worth is below its 50-day moving average of $114.72 and below its 200-day moving average of $108.17.4. Spirit Realty Capital (SRC)
16.1% sales growth and 4.36% return on equity
Spirit Realty Capital, Inc. (NYSE: SRC) is a premier net-lease REIT that primarily invests in single-tenant, operationally essential real estate assets, subject to long-term leases.
Spirit Realty Capital's sales growth this year is anticipated to be 24.5% and 9.5% for next year.
Year-on-year quarterly revenue growth grew by 34.3%, now sitting on 580.95M for the twelve trailing months.
Volume
Today's last reported volume for Spirit Realty Capital is 55665 which is 94.21% below its average volume of 961703.
Spirit Realty Capital's sales growth for the next quarter is 16.1%. The company's growth estimates for the ongoing quarter and the next is 41.7% and 925%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.36%.
Volatility
Spirit Realty Capital's last day, last week, and last month's current intraday variation average was 1.10%, 1.01%, and 1.25%, respectively.
Spirit Realty Capital's highest amplitude of average volatility was 4.45% (day), 2.60% (last week), and 2.40% (last month), respectively.
Spirit Realty Capital's Stock Yearly Top and Bottom Value
Spirit Realty Capital's stock is valued at $46.05 at 10:22 EST, way under its 52-week high of $52.29 and way higher than its 52-week low of $39.50.
Spirit Realty Capital's Moving Average
Spirit Realty Capital's value is under its 50-day moving average of $46.99 and below its 200-day moving average of $48.22.5. Farmers National Banc Corp. (FMNB)
14.6% sales growth and 16.03% return on equity
Farmers National Banc Corp., a financial holding company, operates in the banking, trust, retirement consulting, insurance, and financial management industries.
Farmers National Banc Corp.'s sales growth this year is expected to be 11.9% and 11.7% for next year.
Year-on-year quarterly revenue growth grew by 18.6%, now sitting on 141.77M for the twelve trailing months.
Volume
Today's last reported volume for Farmers National Banc Corp. is 58969 which is 31.62% below its average volume of 86246.
Farmers National Banc Corp.'s sales growth for the next quarter is 14.6%. The company's growth estimates for the present quarter and the next is 5% and negative -9.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.03%.
Volatility
Farmers National Banc Corp.'s last day, last week, and last month's current intraday variation average was 3.12%, 1.16%, and 1.20%, respectively.
Farmers National Banc Corp.'s highest amplitude of average volatility was 3.11% (day), 2.83% (last week), and 2.87% (last month), respectively.
Farmers National Banc Corp.'s Stock Yearly Top and Bottom Value
Farmers National Banc Corp.'s stock is valued at $17.53 at 10:22 EST, way under its 52-week high of $20.00 and way higher than its 52-week low of $14.06.
Farmers National Banc Corp.'s Moving Average
Farmers National Banc Corp.'s worth is under its 50-day moving average of $18.19 and higher than its 200-day moving average of $16.95.6. Sapiens International Corporation N.V. (SPNS)
8.2% sales growth and 11.93% return on equity
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa.
Sapiens International Corporation N.V.'s sales growth this year is expected to be 8% and 10% for next year.
Year-on-year quarterly revenue growth grew by 17.3%, now sitting on 461.04M for the twelve trailing months.
Volume
Today's last reported volume for Sapiens International Corporation N.V. is 51234 which is 33.52% below its average volume of 77072.
Sapiens International Corporation N.V.'s sales growth for the next quarter is 8.2%. The company's growth estimates for the current quarter and the next is a negative 0% and negative -3.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.93%.
Volatility
Sapiens International Corporation N.V.'s last day, last week, and last month's current intraday variation average was 3.73%, 2.61%, and 2.32%, respectively.
Sapiens International Corporation N.V.'s highest amplitude of average volatility was 4.17% (day), 4.97% (last week), and 3.52% (last month), respectively.
Sapiens International Corporation N.V.'s Stock Yearly Top and Bottom Value
Sapiens International Corporation N.V.'s stock is valued at $27.26 at 10:22 EST, way below its 52-week high of $38.32 and way above its 52-week low of $24.30.